MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 266 filers reported holding MIRATI THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $4,566,000 | +15.4% | 55,537 | +105.9% | 0.00% | 0.0% |
Q4 2021 | $3,957,000 | -54.9% | 26,976 | -45.6% | 0.00% | -60.0% |
Q3 2021 | $8,772,000 | +90.4% | 49,582 | +73.9% | 0.01% | +66.7% |
Q2 2021 | $4,607,000 | -3.4% | 28,519 | +2.4% | 0.00% | 0.0% |
Q1 2021 | $4,768,000 | -41.6% | 27,837 | -25.2% | 0.00% | -40.0% |
Q4 2020 | $8,169,000 | +79.2% | 37,191 | +35.5% | 0.01% | +66.7% |
Q3 2020 | $4,559,000 | +167.7% | 27,455 | +84.1% | 0.00% | +200.0% |
Q2 2020 | $1,703,000 | +124.1% | 14,917 | +50.9% | 0.00% | 0.0% |
Q1 2020 | $760,000 | -59.6% | 9,888 | -32.3% | 0.00% | 0.0% |
Q4 2019 | $1,882,000 | +53.9% | 14,607 | -6.9% | 0.00% | 0.0% |
Q3 2019 | $1,223,000 | -33.1% | 15,692 | -11.6% | 0.00% | -50.0% |
Q2 2019 | $1,828,000 | +87.3% | 17,749 | +33.3% | 0.00% | +100.0% |
Q1 2019 | $976,000 | +5.6% | 13,314 | -32.2% | 0.00% | 0.0% |
Q3 2018 | $924,000 | -40.5% | 19,623 | -37.7% | 0.00% | 0.0% |
Q2 2018 | $1,553,000 | – | 31,511 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 2,881,702 | $14,985,000 | 6.99% |
Avoro Capital Advisors LLC | 2,383,201 | $12,393,000 | 1.58% |
Broadfin Capital, LLC | 2,090,801 | $10,872,000 | 1.32% |
Boxer Capital, LLC | 1,037,994 | $5,398,000 | 1.18% |
Ghost Tree Capital, LLC | 172,184 | $895,000 | 0.17% |
Baker Brothers Advisors | 2,269,198 | $11,800,000 | 0.10% |
Hillhouse Capital Management | 725,000 | $3,770,000 | 0.07% |
SABBY MANAGEMENT, LLC | 249,735 | $1,299,000 | 0.07% |
Rhenman & Partners Asset Management AB | 50,000 | $260,000 | 0.04% |
Trexquant Investment LP | 42,879 | $223,000 | 0.03% |